The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy

Ning Yang Wen-jing Yun Zheng-guo Cui Hua-chuan Zheng a Department of Oncology and Central Laboratory,The Affiliated Hospital of Chengde Medical University,Chengde,Chinab Department of Environmental Health,University of Fukui School of Medical Science,Fukui,Japan
DOI: https://doi.org/10.1080/01443615.2024.2347430
2024-06-06
Journal of Obstetrics and Gynaecology
Abstract:Background At present, the discovery of new biomarkers is of great significance for the early diagnosis, treatment and prognosis assessment of ovarian cancer. Previous findings indicated that aberrant G-protein-coupled receptor 176 (GPR176) expression might contribute to tumorigenesis and subsequent progression. However, the expression of GPR176 and the molecular mechanisms in ovarian cancer had not been investigated.
obstetrics & gynecology
What problem does this paper attempt to address?